Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular FeaturesYuko Omori, Shinya Tanaka, Hiroyuki Maguchi et al.|Gastroenterology|2018Cited by 180
Phase 2 Study of Neoadjuvant Treatment of Sequential S-1-Based Concurrent Chemoradiation Therapy Followed by Systemic Chemotherapy with Gemcitabine for Borderline Resectable Pancreatic Adenocarcinoma (HOPS-BR 01)Tsuyoshi Hayashi, Satoshi Hirano, Toru Nakamura et al.|International Journal of Radiation Oncology*Biology*Physics|2019Cited by 26
An intact boundary between the tumor and inner hypoechoic layer discriminates T1 lesions among sessile elevated gallbladder cancersHaruka Toyonaga, Akio Katanuma, Tsuyoshi Hayashi et al.|Journal of Hepato-Biliary-Pancreatic Sciences|2021Cited by 5
[Clinical features of acute acalculous cholecystits-nosocomial manner and community-acquired manner].Shimpei Matsusaki, Fúmitaka Nakamura, H Maguchi et al.|PubMed|2008Cited by 4
HOPS-R01 phase II trial evaluating neoadjuvant S-1 therapy for resectable pancreatic adenocarcinomaMasahiro Shitani, Tsuyoshi Hayashi, Yasutoshi Kimura et al.|Scientific Reports|2022Cited by 3